Since TNBC patients express none of these three receptors (ER, PR, and HER2) exhibit a worse prognosis, making anti-tumor immune system re-identify tumor cells through inhibiting the programmed cell death 1 pathway became a solution that can be tried (28). Here, PDCD1 is linked to neoplasm.